Pharmaids Pharmaceuticals Limited
BSE: PHARMAID
Prev Close
62.27
Open Price
62
Volume
13,486
Today Low / High
62 / 64
52 WK Low / High
54 / 84.97
Range
59 - 65
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 62, reflecting a change of -0.27 (-0.4336%). The expected target range on the BSE is 59 - 65. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Pharmaids Pharmaceuticals Limited Graph
Pharmaids Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Pharmaids Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 62.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 62.00 | 62.62 | 56.36 - 68.88 |
| 63.24 | 50.59 - 75.89 | ||
| 63.86 | 44.70 - 83.02 | ||
| Bearish Scenario | 62.00 | 61.38 | 55.24 - 67.52 |
| 60.76 | 48.61 - 72.91 | ||
| 60.14 | 42.10 - 78.18 |
Overview of Pharmaids Pharmaceuticals Limited
ISIN
INE117D01018
Industry
Medical - Pharmaceuticals
Vol.Avg
10,061
Market Cap
2,186,603,600
Last Dividend
0
Official Website
IPO Date
DCF Diff
73.27
DCF
-11
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.84 Cr | 2.12 Cr | 2.72 Cr | 0.5622 | 0.00 Cr | 0.00 Cr | -15.20 Cr | -3.94 Cr | -1.11 | -2.01 Cr | -0.8135 |
| 2024-03-31 | 14.60 Cr | 22.39 Cr | -7.80 Cr | -0.5341 | 0.00 Cr | 1.37 Cr | -14.01 Cr | -7.97 Cr | -3.51 | -12.35 Cr | -0.5459 |
| 2023-03-31 | 0.00 Cr | 0.89 Cr | -0.89 Cr | 0.0000 | 0.00 Cr | 0.00 Cr | -9.90 Cr | -7.56 Cr | -5.86 | -9.89 Cr | 0.0000 |
| 2022-03-31 | 3.94 Cr | 3.57 Cr | 0.37 Cr | 0.0934 | 0.00 Cr | 0.05 Cr | 0.13 Cr | 0.15 Cr | 0.14 | 0.14 Cr | 0.0368 |
| 2021-03-31 | 8.55 Cr | 8.16 Cr | 0.39 Cr | 0.0458 | 0.00 Cr | 0.03 Cr | 0.07 Cr | 0.09 Cr | 0.09 | 0.13 Cr | 0.0109 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.14 Cr | 119.85 Cr | 64.81 Cr | 59.3203 Cr | 38.97 Cr | 36.83 Cr | 12.18 Cr | 49.18 Cr | 0.00 Cr | 0.00 Cr | 5.58 Cr | 28.7145 Cr |
| 2024-03-31 | 4.80 Cr | 91.34 Cr | 20.84 Cr | 72.0470 Cr | 8.53 Cr | 3.73 Cr | 3.59 Cr | 38.46 Cr | 0.05 Cr | 0.00 Cr | 0.14 Cr | 11.5758 Cr |
| 2023-03-31 | 12.75 Cr | 24.59 Cr | 2.13 Cr | 22.4601 Cr | 0.00 Cr | -12.75 Cr | -0.07 Cr | 2.11 Cr | 0.00 Cr | 0.00 Cr | 2.10 Cr | 2.1273 Cr |
| 2022-03-31 | 0.41 Cr | 11.11 Cr | 2.44 Cr | 8.6716 Cr | 0.00 Cr | -0.41 Cr | 0.89 Cr | 0.48 Cr | 0.00 Cr | 0.00 Cr | 7.51 Cr | 2.4407 Cr |
| 2021-03-31 | 0.20 Cr | 9.12 Cr | 0.59 Cr | 8.5264 Cr | 0.00 Cr | -0.20 Cr | 0.37 Cr | 0.49 Cr | 0.00 Cr | 0.00 Cr | 7.32 Cr | 0.5886 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -13.9912 Cr | -12.0237 Cr | 23.3555 Cr | -26.4720 Cr | -2.6595 Cr | 2.1445 Cr | -12.4808 Cr | -3.9388 Cr | 27.7855 Cr | 0.0000 Cr | -8.5933 Cr |
| 2024-03-31 | -11.6480 Cr | -74.9904 Cr | 78.8965 Cr | -34.7188 Cr | -7.9502 Cr | 4.8040 Cr | -22.8625 Cr | -7.9680 Cr | -0.2655 Cr | 0.0000 Cr | 0.7164 Cr |
| 2023-03-31 | -4.0193 Cr | -4.9433 Cr | 21.3094 Cr | -5.6922 Cr | 12.3468 Cr | 12.7542 Cr | -1.6729 Cr | -9.9076 Cr | 0.0000 Cr | 0.0000 Cr | 0.8876 Cr |
| 2022-03-31 | -0.2593 Cr | 0.4665 Cr | 0.0000 Cr | -0.2593 Cr | 0.2071 Cr | 0.4074 Cr | 0.0000 Cr | 0.1411 Cr | 0.0000 Cr | 0.0000 Cr | -0.5185 Cr |
| 2021-03-31 | 0.4053 Cr | -0.2268 Cr | 0.0000 Cr | 0.4038 Cr | 0.1785 Cr | 0.2003 Cr | -0.0015 Cr | 0.0884 Cr | 0.0000 Cr | 0.0000 Cr | -0.3691 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 6.66 Cr | 3.51 Cr | 3.16 Cr | 0.4739 | -6.02 Cr | -4.95 Cr | -1.41 | -5.37 Cr | -0.7431 |
| 2025-03-31 | 9.61 Cr | 4.24 Cr | 5.37 Cr | 0.5589 | -4.53 Cr | -7.88 Cr | -2.22 | -8.37 Cr | -0.8197 |
| 2024-12-31 | 4.71 Cr | 2.99 Cr | 1.72 Cr | 0.3647 | -3.52 Cr | -1.93 Cr | -0.55 | -2.89 Cr | -0.4105 |
| 2024-09-30 | 5.24 Cr | 3.51 Cr | 1.73 Cr | 0.3296 | -3.17 Cr | -2.22 Cr | -0.73 | -2.61 Cr | -0.4237 |
| 2024-06-30 | 4.67 Cr | 7.34 Cr | -2.66 Cr | -0.5696 | -3.97 Cr | -2.68 Cr | -0.76 | -3.47 Cr | -0.5743 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.14 Cr | 0.00 Cr | 2.14 Cr | 3.13 Cr | 12.18 Cr | 22.31 Cr | 49.18 Cr | 119.85 Cr | 64.81 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 2.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -64.82 Cr |
| 2024-09-30 | 2.79 Cr | 0.00 Cr | 2.79 Cr | 3.26 Cr | 2.37 Cr | 12.55 Cr | 40.47 Cr | 94.60 Cr | 29.78 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 4.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -70.50 Cr |
| 2024-03-31 | 4.80 Cr | 0.44 Cr | 4.80 Cr | 2.70 Cr | 3.61 Cr | 13.53 Cr | 38.46 Cr | 91.34 Cr | 20.84 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.90 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -1.93 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -2.22 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -2.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -4.53 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born: 1969
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born: 1984
Gender: female
Year Born:
Gender: Not Specified
Year Born: 1997
Gender: Not Specified
Year Born: 1976
FAQs about Pharmaids Pharmaceuticals Limited
The CEO is Prasad S..
The current price is ₹62.00.
The range is ₹54-84.97.
The market capitalization is ₹218.66 crores.
The P/E ratio is -12.82.
The company operates in the Healthcare sector.
Overview of Pharmaids Pharmaceuticals Limited (ISIN: INE117D01018) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹218.66 crores and an average daily volume of 10,061 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.